Mariner Wealth Advisors (NYC)’s Biogen BIIB Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$48K	Buy	+113	New	+$44.5K	0.02%	159

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s BIIB Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Biogen (BIIB) in Q1 2015: 113 shares worth $48K. The stake represents 0.02% of the portfolio and ranks #159 among its holdings.

967 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

Mariner Wealth Advisors (NYC) held 113 shares of Biogen worth $48K as of Q1 2015.
Biogen was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Biogen made up 0.02% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #159 holding.
967 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.